WHAT’S KNOWN
Pulmonary thromboembolism is one of the leading causes of death due to
its high morbidity and mortality. When early diagnosis and treatment is
made, there is a serious decrease in mortality rates. Therefore,
biomarkers are very important for effective and accurate determinations
in the diagnosis, treatment monitoring and result of PTE disease. The
currently available diagnostic technology for PTE detection is not
specific.